| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7514032 | International Journal of Drug Policy | 2014 | 9 Pages |
Abstract
Harm reduction programs often neglect chemicals that are not narcotics, not related to sexually transmitted infections, and which are legally and freely available. Safety issues arise when otherwise safe products are used off-label in large quantities. Drug policy-makers are paying insufficient attention to the safety of cosmetics.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Nurul Ilmi Idrus, Takeo David Hymans,